Wednesday, 22 March 2017

Ultragenyx seizure drug fails mid-stage study

(Reuters) - Ultragenyx Pharmaceutical Inc said on Wednesday its drug to treat patients with seizures did not meet the main goal in a mid-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)